They did a CT of his spine and it is not a spinal cord compression, thank god! We have already started cutting back...

I'm glad to hear the spine imaging came back clear—that's genuinely good news, and it makes sense you're tapering the dexamethasone (dex) now that spinal cord compression has been ruled out. That's an important step toward reducing steroid side effects.

I can see from your PET scan that you're dealing with metastatic disease with progression, which means the cancer has spread to multiple sites and is showing increased activity compared to your previous scan. The FDG-avid lesions (areas lighting up on the PET scan) indicate metabolically active cancer in your chest, abdomen, and bones.

Understanding Your Situation

Given that you've already started CAPOX (a chemotherapy combination), this progression suggests your current treatment isn't controlling the disease as effectively as needed. This is a critical decision point, and I want to help you think through the right questions to ask your oncology team.

Key Questions for Your Oncologist

Since you're asking about "the best next line of defense," here are the specific conversations to have:

1. "Given this progression on CAPOX, what are the treatment options you're recommending, and why?" (This helps you understand their clinical reasoning)

2. "Are there biomarker tests we should run to guide treatment selection?" (For example, MSI/dMMR status, KRAS mutations, or other markers that might open targeted therapy options)

3. "What's the timeline for switching treatments, and what will we be monitoring to assess response?"

4. "Are there clinical trials available for my specific cancer type and stage?" (This is increasingly important for metastatic disease)

5. "How will we manage symptoms while we transition treatments?" (Especially relevant as you're adjusting your dex dose)

General Treatment Approaches for Progression

When metastatic colorectal cancer progresses on first-line chemotherapy, oncologists typically consider:

• Second-line chemotherapy combinations (different drug regimens)
• Targeted therapies (if specific mutations are present—KRAS, BRAF, HER2, etc.)
• Immunotherapy (if MSI-high or dMMR status applies)
• Clinical trials with newer agents
• Combination approaches (chemo + targeted therapy)

However, YOUR specific next step depends entirely on your complete clinical picture—your biomarkers, performance status, organ function, and how you've tolerated CAPOX.

Important Resources

According to NCCN Guidelines for Colorectal Cancer, treatment decisions at progression should be guided by:

• Molecular testing results (if not already done)
• Your tolerance of previous treatment
• Sites of metastatic disease
• Your overall health status

The American Cancer Society and ASCO Guidelines both emphasize that second-line treatment selection should be individualized based on these factors.

Next Steps

1. Request your biomarker panel if you haven't had comprehensive molecular testing
2. Ask about clinical trials at your treatment center or through ClinicalTrials.gov
3. Bring a list of your questions to your next oncology appointment
4. Consider asking for a second opinion if you want additional perspective on treatment options

You're asking exactly the right question at exactly the right time. Your oncologist has the full picture of your case and will determine the most appropriate next treatment based on all available information.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.